Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -9.09%14 Days Payable is 79.86 as of Dec. 2025, which is 444% above its 10-year median of 14.69. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, NewGenIvf Group ranks better than 81.85% on this metric.
The historical rank and industry rank for NewGenIvf Group's Days Payable or its related term are showing as below:
NIVF'
s Days Payable Range Over the Past 10 Years
Min: 5.55 Med: 14.69 Max: 165.8
Current: 165.8
During the past 5 years, NewGenIvf Group's highest Days Payable was 165.80. The lowest was 5.55. And the median was 14.69.
NIVF's Days Payable is ranked better than 81.85% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.015
vs NIVF: 165.80
NewGenIvf Group's Days Payable
increased
from Sep. 2024 (19.16) to Dec. 2025 (79.86).
It may suggest that NewGenIvf Groupdelayed paying its suppliers.
NewGenIvf Group Days Payable Related Terms
NewGenIvf Group Days Payable Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, NewGenIvf Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Days Payable distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NewGenIvf Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewGenIvf Group (NIVF) has a Days Payable of 79.86 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NewGenIvf Group and its competitors. This is 444% above median its historical median of 14.69. Over the past decade, NewGenIvf Group's Days Payable has ranged from 5.55 to 165.80. According to the industry distribution chart, NewGenIvf Group ranks #110 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 18.2%.
Is NewGenIvf Group's Days Payable too high?
NewGenIvf Group's current Days Payable of 79.86 is 444% above median its 10-year median of 14.69. Over the past 10 years, this metric has ranged from a low of 5.55 to a high of 165.80. The Healthcare Providers & Services industry median Days Payable is 57.02. NewGenIvf Group's value of 79.86 is 40.1% above this industry median. Based on the distribution chart, NewGenIvf Group ranks #110 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Days Payable compare to RHEP and XCRT?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #110 out of 606 companies for Days Payable. This places NewGenIvf Group in the top 18% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.02. NewGenIvf Group's value of 79.86 is 40.1% above this benchmark. Historically, NewGenIvf Group's own Days Payable has ranged from 5.55 to 165.80 over the past decade. While the company's 10-year median is 14.69 vs. the industry median of 57.02, NewGenIvf Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.02, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewGenIvf Group's current Days Payable of 79.86 is 40.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NewGenIvf Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current Days Payable is 79.86, which is 444% above median its own 10-year median of 14.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Days Payable of 79.86. The current Days Payable is 79.86, which is 444% above median its 10-year median of 14.69 and 40.1% above the Healthcare Providers & Services industry median of 57.02. NewGenIvf Group's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Days Payable is 79.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
